Filgrastim biosimilar (Chalver Laboratorios)

非格司亭生物类似药（Chalver Laboratorios）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Chalver Laboratorios)

Drug Alias Name非格司亭生物仿制药（Chalver Laboratorios）rhG-CSF (Chalver Laboratorios)Recombinant human granulocyte macrophage colony stimulating factor (Chalver Laboratorios)Leucosos

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryColombia

Original Approved Date2012/01/01

Country/TerritoryColombia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesChalver Laboratorios

China Registration ClassN/A

Develop Information

Active CompaniesChalver Laboratorios

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02